ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer

ClinicalTrials.gov ID: NCT01893307

Public ClinicalTrials.gov record NCT01893307. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 4:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT) for the Treatment of Oropharyngeal Cancer of the Head and Neck

Study identification

NCT ID
NCT01893307
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
M.D. Anderson Cancer Center
Other
Enrollment
440 participants

Conditions and interventions

Interventions

  • Intensity-Modulated Radiation Therapy Radiation
  • Laboratory Biomarker Analysis Other
  • Photon Beam Radiation Therapy Radiation
  • Proton Beam Radiation Therapy Radiation
  • Quality-of-Life Assessment Other

Radiation · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 25, 2013
Primary completion
Dec 30, 2031
Completion
Dec 30, 2031
Last update posted
Feb 23, 2026

2013 – 2031

United States locations

U.S. sites
22
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35249
Mayo Clinic in Arizona Scottsdale Arizona 85259
University of Florida Health Science Center - Gainesville Gainesville Florida 32610
Miami Cancer Institute Miami Florida 33176
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322
Northwestern Medicine Cancer Center Warrenville Warrenville Illinois 60555
Willis-Knighton Medical and Cancer Center Shreveport Louisiana 71103
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114
Wayne State University/Karmanos Cancer Institute Detroit Michigan 48201
Mayo Clinic in Rochester Rochester Minnesota 55905
New York Proton Center New York New York 10035
Memorial Sloan Kettering Cancer Center New York New York 10065
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
University of Pennsylvania/Abramson Cancer Center Philadelphia Pennsylvania 19104
MD Anderson in The Woodlands Conroe Texas 77384
M D Anderson Cancer Center Houston Texas 77030
MD Anderson West Houston Houston Texas 77079
MD Anderson League City League City Texas 77573
MD Anderson in Sugar Land Sugar Land Texas 77478
Inova Schar Cancer Institute Fairfax Virginia 22031
Fred Hutch/University of Washington Cancer Consortium Seattle Washington 98109

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01893307, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 23, 2026 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01893307 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →